The Great Britain is witnessing a growing surge in interest surrounding entheogenic substances. Beyond the common use of psilocybin and LSD, investigators and enthusiasts are increasingly exploring less-charted frontiers, particularly the copyright compound and the nascent cannabinoid, cannabigerol. This expanding scene encompasses therapeutic rese